查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1883045

抗生物膜劑市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2024-2032 年）

Anti-Biofilm Agents Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 請詢問到貨日

價格

抗生物膜劑市場成長推動因素

隨著全球慢性及急性傷口負擔的日益加重，全球抗生物膜劑市場持續成長。 2024 年，該市場規模達到 13.8 億美元，主要受生物膜發生率上升、傷口盛行率增加以及對先進傷口護理解決方案的需求增長的推動。預計到 2025 年，該市場規模將達到 15 億美元，主要得益於醫院、傷口診所和家庭護理機構對生物膜產品的日益普及。在產品創新、公眾意識提升和臨床研究活動增加的推動下，預計到2032年，抗生物膜藥物市場將顯著增長至27.4億美元。

北美將引領全球市場，在2024年佔36.95%的市場。這主要歸功於北美地區較高的醫療保健支出水準、完善的傷口管理基礎設施以及先進傷口護理技術的日益普及。

市場推動因素

急性和慢性傷口的增加是推動抗生物膜藥物需求的主要因素。生物膜存在於60%的慢性傷口和10%的急性傷口（MDPI，2024），會顯著延緩傷口癒合並增加感染風險。糖尿病足潰瘍、壓瘡和靜脈性腿部潰瘍是全球慢性傷口盛行率最高的幾種類型。根據美國國家生物技術資訊中心 (NCBI，2023) 的數據，全球 6.3% 的糖尿病患者會發展為糖尿病足潰瘍，其中許多潰瘍與生物膜形成有關。

醫院獲得性壓瘡仍然普遍存在，英國的發生率為 8.7% (2021)。手術部位感染也在增加，全球發生率為 2.5% (美國國家醫學圖書館，2023)。這些因素共同推動了對專用抗生物膜製劑（例如敷料、凝膠和粉末）的需求。

市場限制

儘管需求不斷增長，但由於對生物膜風險缺乏認識以及慢性傷口診斷延遲，發展中國家的採用率仍然有限。發表在 "糖尿病足雜誌" (2023) 上的一項研究發現，診斷延遲時間為 15 至 126 天，這顯著增加了生物膜的風險。保險覆蓋範圍有限、專業傷口護理人員短缺以及傷口護理指南不一致等因素進一步阻礙了印度、中國和巴西等新興地區的市場擴張。

先進的抗生物膜敷料和新型抗菌技術的高昂成本也限制了低收入醫療機構的取得。

市場機會

慢性傷口盛行率的上升正促使各公司加大研發投入並開發新產品。康維特公司2024年的臨床試驗結果表明，其AQUACEL Ag+Extra敷料對靜脈性腿部潰瘍有效，再次印證了銀基抗生物膜技術的作用。同樣，該公司於2023年在美國推出的ConvaFoam敷料也確立了其在廣譜傷口敷料領域的領先創新地位。

世界各地的政府和醫療機構也在開展提高公眾意識的活動，旨在促進早期診斷並提高抗生物膜解決方案的採用率，尤其是在亞太和拉丁美洲地區，這些地區預計將實現長期增長。

市場挑戰

在許多發展中地區，生物膜管理指南並未一致執行。臨床醫生培訓不足、缺乏標準化的傷口評估系統以及抗生物膜療法的不當使用，都會導致生物膜感染發展到晚期，治療效果不佳。此外，高級敷料和專用產品的高昂成本限制了它們在資源匱乏地區的使用。

市場趨勢

創新是塑造市場的核心趨勢。研究越來越集中在奈米技術上，包括銀奈米顆粒、氧化鋅和蜂蜜基抗菌劑。根據美國國家生物技術資訊中心 (NCBI，2022) 的數據，80% 的慢性傷口中存在生物膜，因此對新一代抗生物膜系統有顯著的臨床需求。

領先的公司正與研究機構合作，推進生物膜管理。例如，Asep Medical Holdings 於 2022 年與 iFyber 合作，開發用於傷口護理的新型抗菌勝肽技術。

區域洞察

北美

預計到 2024 年，北美市場規模將達到 5.1 億美元，這主要得益於先進傷口護理技術的廣泛應用和強勁的醫療保健支出。美國仍然是最大的市場貢獻者，這得益於其強大的研發投入和創新抗菌敷料的快速普及。

歐洲

由於慢性傷口的高發生率和較高的臨床意識，歐洲佔了相當大的市場佔有率。像 Molnlycke AB 這樣的公司正積極透過 EWMA 2025 等平台推廣抗菌敷料。

亞太地區

預計亞太地區在 2025 年至 2032 年間將實現最高增長率，這主要得益於研究投入的增加、傷口護理基礎設施的擴建以及人口老齡化導致慢性傷口發生率上升。

拉丁美洲、中東/非洲

成長的推動因素包括燒傷病例的增加、可支配收入的提高以及醫院基礎設施的擴建。巴西每年報告 100 萬例燒傷病例，凸顯了該地區的強勁需求。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要疾病流行情況（主要國家/地區，2023/2024 年）
  • 主要產業趨勢－併購與合作
  • 產品詳情：抗生物膜劑、主要廠商

第五章：全球抗生物膜劑市場分析、洞察與預測 （2019-2032）

  • 市場分析、洞察與預測 - 依產品分類
    • 敷料
    • 軟膏/凝膠
    • 粉劑
  • 市場分析、洞察與預測 - 依分子分類
    • 銀
    • 碘
    • 蜂蜜
    • 其他
  • 市場分析、洞察與預測 - 依傷口類型分類
    • 慢性傷口
    • 急性傷口
  • 市場分析、洞察與預測 - 依最終用戶分類
    • 醫院
    • 傷口診所
    • 家庭醫療保健機構
    • 其他
  • 市場分析、洞察與預測 - 依地區分類
    • 北部美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美抗生物膜劑市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲抗生物膜劑市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 歐洲其他地區

第八章 亞太地區抗生物膜劑市場分析洞察與預測（2019-2032）

  • 依國家劃分
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲抗生物膜劑市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲抗生物膜劑市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 海灣合作委員會
    • 南亞非洲
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2024 年）
  • 公司簡介
  • 康維特公司 (Convatec Inc.)
  • 史密斯醫療 (Smith+Nephew)
  • 科樂普公司 (Coloplast A/S)
  • 索爾文圖姆公司 (Solventum)
  • 莫爾尼克公司 (Molnlycke AB)
  • URGO MEDICAL
  • Imbed Biosciences
Product Code: FBI113668

Growth Factors of anti-biofilm agents Market

The global anti-biofilm agents market continues to gain traction as the burden of chronic and acute wounds rises worldwide. In 2024, the market was valued at USD 1.38 billion, supported by increasing biofilm formation cases, higher wound prevalence, and a growing shift toward advanced wound care solutions. The market is expected to reach USD 1.50 billion in 2025, driven by increasing adoption of anti-biofilm products across hospitals, wound clinics, and home care settings. By 2032, the anti-biofilm agents market is projected to grow significantly to USD 2.74 billion, fueled by product innovation, growing awareness, and increased clinical research activity.

North America dominated the global market in 2024, capturing 36.95% of total share, largely due to high healthcare spending, strong wound management infrastructure, and rising adoption of advanced wound care technologies.

Market Drivers

The rise in acute and chronic wounds is the primary driver of anti-biofilm agent demand. Biofilms, which occur in 60% of chronic wounds and 10% of acute wounds (MDPI, 2024), significantly delay healing and increase the risk of infection. Diabetic foot ulcers, pressure ulcers, and venous leg ulcers represent the largest contributor to chronic wound prevalence worldwide. According to NCBI (2023), 6.3% of diabetic patients globally develop diabetic foot ulcers, many of which involve biofilm formation.

Hospital-acquired pressure ulcers remain widespread, with incidence rates reaching 8.7% in the U.K. (2021). Surgical site infections are also on the rise, with a global pooled incidence of 2.5% (National Library of Medicine, 2023). These factors collectively increase the need for specialized anti-biofilm agents, including dressings, gels, and powders.

Market Restraints

Despite rising demand, adoption in developing nations remains limited due to low awareness of biofilm risks and delayed diagnosis of chronic wounds. A study published in The Diabetic Foot Journal (2023) found diagnostic delays ranging from 15 to 126 days, significantly increasing biofilm risk. Limited reimbursement, lack of specialist wound-care professionals, and inconsistent wound-care guidelines further hinder market expansion in emerging regions such as India, China, and Brazil.

The high cost of advanced anti-biofilm dressings and novel antimicrobial technologies also limits access in low-income healthcare settings.

Market Opportunities

The rising prevalence of chronic wounds is encouraging companies to increase R&D investments and pursue new product development. Convatec's 2024 clinical results demonstrated the effectiveness of its AQUACEL Ag+ Extra dressing in venous leg ulcers, reaffirming the role of silver-based anti-biofilm technologies. Similarly, the company's 2023 U.S. launch of ConvaFoam positioned it as a key innovator in broad-spectrum wound dressings.

Governments and healthcare organizations globally are also launching awareness initiatives to promote early diagnosis and improve adoption of anti-biofilm solutions, particularly in Asia Pacific and Latin America-regions expected to show strong long-term growth.

Market Challenges

Biofilm management guidelines are not implemented consistently across many developing regions. Limited clinician training, lack of standardized wound assessment systems, and inconsistent use of anti-biofilm therapies contribute to late-stage biofilm infections and poor outcomes. Additionally, the high cost of advanced dressings and specialized products restricts usage in resource-constrained settings.

Market Trends

Innovation is a core trend shaping the market. Studies are increasingly focused on nanotechnology, including silver nanoparticles, zinc oxide, and honey-based antimicrobials. According to NCBI (2022), 80% of chronic wounds contain biofilms, creating a significant clinical need for next-generation anti-biofilm systems.

Key players are partnering with research organizations to advance biofilm management. For example, Asep Medical Holdings partnered with iFyber in 2022 to develop novel antimicrobial peptide technologies for wound care applications.

Regional Insights

North America

North America accounted for USD 0.51 billion in 2024, driven by high adoption of advanced wound care and robust healthcare expenditure. The U.S. remains the largest contributor due to strong R&D funding and rapid uptake of innovative antimicrobial dressings.

Europe

Europe holds a significant market share due to high chronic wound prevalence and strong clinical awareness. Companies such as Molnlycke AB actively promote antimicrobial dressings through platforms like EWMA 2025.

Asia Pacific

Asia Pacific is expected to record the highest growth between 2025 and 2032, supported by rising research activity, expanding wound care infrastructure, and growing cases of chronic wounds across aging populations.

Latin America & Middle East/Africa

Growth is driven by increasing burn injuries, rising disposable income, and expanding hospital infrastructure. Brazil reports 1 million burn cases annually, highlighting strong regional demand.

Conclusion

With market value rising from USD 1.38 billion in 2024 to USD 2.74 billion by 2032, the anti-biofilm agents market is set for strong expansion. Growing wound prevalence, rising R&D investments, and rapid innovation in antimicrobial technologies will continue driving global adoption throughout the forecast period.

Segmentation

By Product

  • Dressings
  • Ointments / Gels
  • Powders

By Molecule

  • Silver
  • Iodine
  • Honey
  • Others

By Wound Type

  • Chronic Wounds
  • Acute Wounds

By End User

  • Hospitals
  • Wound Clinics
  • Home Care Settings
  • Others

By Region

  • North America (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • U.S.
    • Canada
  • Europe (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, Key Countries, 2023/2024
  • 4.2. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.3. Detailed Product Offerings: Anti-biofilm Agents, Key Players

5. Global Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Dressings
    • 5.1.2. Ointments / Gels
    • 5.1.3. Powders
  • 5.2. Market Analysis, Insights and Forecast - By Molecule
    • 5.2.1. Silver
    • 5.2.2. Iodine
    • 5.2.3. Honey
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Wound Type
    • 5.3.1. Chronic Wounds
    • 5.3.2. Acute Wounds
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals
    • 5.4.2. Wound Clinics
    • 5.4.3. Homecare Settings
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Dressings
    • 6.1.2. Ointments / Gels
    • 6.1.3. Powders
  • 6.2. Market Analysis, Insights and Forecast - By Molecule
    • 6.2.1. Silver
    • 6.2.2. Iodine
    • 6.2.3. Honey
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Wound Type
    • 6.3.1. Chronic Wounds
    • 6.3.2. Acute Wounds
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals
    • 6.4.2. Wound Clinics
    • 6.4.3. Homecare Settings
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Dressings
    • 7.1.2. Ointments / Gels
    • 7.1.3. Powders
  • 7.2. Market Analysis, Insights and Forecast - By Molecule
    • 7.2.1. Silver
    • 7.2.2. Iodine
    • 7.2.3. Honey
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Wound Type
    • 7.3.1. Chronic Wounds
    • 7.3.2. Acute Wounds
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals
    • 7.4.2. Wound Clinics
    • 7.4.3. Homecare Settings
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Russia
    • 7.5.7. Rest of Europe

8. Asia Pacific Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Dressings
    • 8.1.2. Ointments / Gels
    • 8.1.3. Powders
  • 8.2. Market Analysis, Insights and Forecast - By Molecule
    • 8.2.1. Silver
    • 8.2.2. Iodine
    • 8.2.3. Honey
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Wound Type
    • 8.3.1. Chronic Wounds
    • 8.3.2. Acute Wounds
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals
    • 8.4.2. Wound Clinics
    • 8.4.3. Homecare Settings
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. China
    • 8.5.2. India
    • 8.5.3. Japan
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Dressings
    • 9.1.2. Ointments / Gels
    • 9.1.3. Powders
  • 9.2. Market Analysis, Insights and Forecast - By Molecule
    • 9.2.1. Silver
    • 9.2.2. Iodine
    • 9.2.3. Honey
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Wound Type
    • 9.3.1. Chronic Wounds
    • 9.3.2. Acute Wounds
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals
    • 9.4.2. Wound Clinics
    • 9.4.3. Homecare Settings
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle Est & Africa Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Dressings
    • 10.1.2. Ointments / Gels
    • 10.1.3. Powders
  • 10.2. Market Analysis, Insights and Forecast - By Molecule
    • 10.2.1. Silver
    • 10.2.2. Iodine
    • 10.2.3. Honey
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Wound Type
    • 10.3.1. Chronic Wounds
    • 10.3.2. Acute Wounds
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals
    • 10.4.2. Wound Clinics
    • 10.4.3. Homecare Settings
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Convatec Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Smith+Nephew
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Coloplast A/S
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Solventum
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Molnlycke AB
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. URGO MEDICAL
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Imbed Biosciences
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 2: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 3: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 4: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 5: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 6: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 7: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 8: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 9: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 10: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 11: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 12: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 13: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 14: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 15: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 16: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 17: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 18: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 19: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 20: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 22: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 23: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 24: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 25: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 26: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 27: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 28: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 29: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 30: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Anti-biofilm Agents Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Anti-biofilm Agents Market Value Share (%), by Product, 2024 & 2032
  • Figure 3: Global Anti-biofilm Agents Segmental Opportunity Index, By Product, 2024
  • Figure 4: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Product, 2024 & 2032
  • Figure 5: Global Anti-biofilm Agents Market Value Share (%), by Molecule, 2024 & 2032
  • Figure 6: Global Anti-biofilm Agents Segmental Opportunity Index, By Molecule, 2024
  • Figure 7: Global Anti-biofilm Agents Segmental Opportunity Index, By Molecule, 2024
  • Figure 8: Global Anti-biofilm Agents Market Value Share (%), by Wound Type, 2024 & 2032
  • Figure 9: Global Anti-biofilm Agents Segmental Opportunity Index, By Wound Type, 2024
  • Figure 10: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Wound Type, 2024 & 2032
  • Figure 11: Global Anti-biofilm Agents Market Value Share (%), by End User, 2024 & 2032
  • Figure 12: Global Anti-biofilm Agents Segmental Opportunity Index, By End User, 2024
  • Figure 13: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By End User, 2024 & 2032
  • Figure 14: Global Anti-biofilm Agents Market Value Share (%), by Region, 2024 & 2032
  • Figure 15: Global Anti-biofilm Agents Segmental Opportunity Index, By Region, 2024
  • Figure 16: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Region, 2024 & 2032
  • Figure 17: North America Anti-biofilm Agents Market Value (USD billion), by Product, 2024 & 2032
  • Figure 18: North America Anti-biofilm Agents Market Value Share (%), by Product, 2024
  • Figure 19: North America Anti-biofilm Agents Market Value (USD billion), by Molecule, 2024 & 2032
  • Figure 20: North America Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2024 & 2032
  • Figure 21: North America Anti-biofilm Agents Market Value (USD billion), by End User, 2024 & 2032
  • Figure 22: North America Anti-biofilm Agents Market Value (USD billion), By Country, 2024 & 2032
  • Figure 23: Europe Anti-biofilm Agents Market Value (USD billion), by Product, 2024 & 2032
  • Figure 24: Europe Anti-biofilm Agents Market Value Share (%), by Product, 2024
  • Figure 25: Europe Anti-biofilm Agents Market Value (USD billion), by Molecule, 2024 & 2032
  • Figure 26: Europe Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2024 & 2032
  • Figure 27: Europe Anti-biofilm Agents Market Value (USD billion), by End User, 2024 & 2032
  • Figure 28: Europe Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 29: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Product, 2024 & 2032
  • Figure 30: Asia Pacific Anti-biofilm Agents Market Value Share (%), by Product, 2024
  • Figure 31: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Molecule, 2024 & 2032
  • Figure 32: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2024 & 2032
  • Figure 33: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by End User, 2024 & 2032
  • Figure 34: Asia Pacific Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 35: Latin America Anti-biofilm Agents Market Value (USD billion), by Product, 2024 & 2032
  • Figure 36: Latin America Anti-biofilm Agents Market Value Share (%), by Product, 2024
  • Figure 37: Latin America Anti-biofilm Agents Market Value (USD billion), by Molecule, 2024 & 2032
  • Figure 38: Latin America Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2024 & 2032
  • Figure 39: Latin America Anti-biofilm Agents Market Value (USD billion), by End User, 2024 & 2032
  • Figure 40: Latin America Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 41: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Product, 2024 & 2032
  • Figure 42: Middle East & Africa Anti-biofilm Agents Market Value Share (%), by Product, 2024
  • Figure 43: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Molecule, 2024 & 2032
  • Figure 44: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2024 & 2032
  • Figure 45: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by End User, 2024 & 2032
  • Figure 46: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 47: Global Anti-biofilm Agents Market Share (%), By Company, 2024